Valuation: Enovis Corporation

Market Cap 1.48B 1.28B 1.2B 1.09B 2.05B 142B 2.08B 14.09B 5.52B 70.86B 5.55B 5.43B 236B P/E 2026 *
88.4x
P/E 2027 * 23.8x
Enterprise Value 2.69B 2.33B 2.19B 1.99B 3.74B 258B 3.8B 25.67B 10.06B 129B 10.11B 9.89B 430B EV / Sales 2026 *
1.15x
EV / Sales 2027 * 1.04x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+3.64%
1 week+5.78%
Current month-12.04%
1 month-5.28%
3 months+5.56%
6 months+18.54%
Current year-3.75%
1 week 23.62
Extreme 23.625
26.44
1 month 23.62
Extreme 23.625
31.66
Current year 19.14
Extreme 19.14
31.66
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
65.03
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
6/30/26 A Free

Director

846 0.0015%
3/31/26 A Free

Director

770 0.0013%
3/7/26 A Tax

Head of Human Resources

28,555 0.0500%
Change 5-day change 1-year change 3-year change Capi.($)
+3.64%+5.78%-13.23%-53.35% 1.43B
-0.09%-4.18%-13.23%+19.23% 127B
+2.07%+0.45%-17.47%+2.59% 12.41B
-0.79%+1.50%+104.93%+155.37% 10.94B
-2.05%-7.70%-46.42%-68.85% 4.45B
+0.11%-0.45%-25.69%+42.67% 2.67B
-0.70%-3.11%-21.90%-14.22% 1.66B
+0.28%-3.92%-34.62%-72.80% 1.65B
-1.01%-3.26%-35.17%-36.93% 1.64B
Average +0.16%-2.09%-11.42%-2.92% 18.23B
Weighted average by Cap. -0.00%-3.42%-7.30%+22.58%

Financials

2026 *2027 *
Net sales 2.34B 2.02B 1.9B 1.73B 3.25B 224B 3.3B 22.31B 8.74B 112B 8.79B 8.6B 374B 2.45B 2.12B 1.99B 1.81B 3.41B 235B 3.46B 23.4B 9.17B 118B 9.22B 9.02B 392B
Net income 11.5M 9.93M 9.35M 8.49M 15.98M 1.1B 16.21M 110M 42.96M 551M 43.18M 42.24M 1.84B 60.85M 52.56M 49.45M 44.94M 84.53M 5.83B 85.77M 580M 227M 2.92B 228M 224M 9.71B
Net Debt 1.21B 1.05B 987M 897M 1.69B 116B 1.71B 11.58B 4.54B 58.21B 4.56B 4.46B 194B 1.08B 937M 882M 801M 1.51B 104B 1.53B 10.34B 4.05B 51.99B 4.07B 3.98B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
18/08/26 $25.64 +3.64% 807,479
17/08/26 $24.74 -5.07% 1,089,524
14/08/26 $26.06 +1.56% 867,528
13/08/26 $25.66 +3.93% 1,018,447
12/08/26 $24.69 +0.37% 1,143,331
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
25.64USD
Average target price
40.83USD
Spread / Average Target
+59.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock